Mexico - North America Antibiotics Market Size & Outlook

Name: Mexico - North America Antibiotics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The antibiotics market in Mexico - North America is expected to reach a projected revenue of US$ 1,448.4 million by 2033. A compound annual growth rate of 6.7% is expected of Mexico - North America antibiotics market from 2026 to 2033.

Mexico antibiotics action mechanism outlook (Revenue, USD million, 2021-2033)
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
Mexico antibiotics type outlook (Revenue, USD million, 2021-2033)
- Branded Antibiotics
- Generic Antibiotics
Mexico antibiotics drug class outlook (Revenue, USD million, 2021-2033)
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamides
- 7-ACA
- Others

Mexico - North America Antibiotics Market Size & Outlook

Sign up - it's easy, and free!